Company: TEM
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000950170-25-025603
Chunk: 229

Company: Tempus AI, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 1
Chunk 229
---
 shares at December 31, 2024 and December 31, 2023, at cost

    (3,602
    )

    (3,602
    )

    Additional Paid-In Capital

    2,210,664

    18,345

    Accumulated Other Comprehensive Income

    94

    5

    Accumulated deficit

    (2,150,834
    )

    (1,396,917
    )

    Total Stockholders' equity (deficit)
     
    $
    56,339

    $
    (1,382,163
    )

    Total Liabilities, Convertible redeemable preferred stock,   and Stockholders' equity (deficit)
     
    $
    926,116

    $
    564,052

The accompanying notes are an integral part of these consolidated financial statements.

140

Tempus AI, Inc. 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 

(in thousands, except per share amounts) 

    Year Ended December 31,

    2024

    2023

    2022

    Net revenue

    Genomics
    $
    451,749

    $
    363,022

    $
    197,984

    Data and services
     
    241,649

    168,800

    122,684

    Total net revenue
    $
    693,398

    $
    531,822

    $
    320,668

    Cost and operating expenses

    Cost of revenues, genomics
     
    243,467

    189,165

    150,255

    Cost of revenues, data and services
     
    68,818

    56,482

    40,227

    Technology research and development
     
    167,519

    95,155

    79,093

    Research and development
     
    149,325

    90,343

    83,158

    Selling, general and administrative
     
    755,351

    296,760

    233,377

    Total cost and operating expenses
     
    1,384,480

    727,905

    586,110

    Loss from operations
    $
    (691,082
    )